2013 Project Highlights
The first new nuclear power project in decades is under multiple spotlights. CCA helped prepare witnesses for regulatory proceedings occurring during the course of construction. Several important construction, schedule, and cost issues specific to new nuclear development were considered as part of these proceedings.
Conflict at Every Milestone
A new clean coal power plant has a history of permit issues, certificate revocations, court decisions, appeals, and a multi-billion-dollar price tag. CCA worked with the company as it prepared to deal with regulators, legislators, intervenors and the state supreme court.
Oil pipelines face continuing operational and reputational challenges from regulators and the public. CCA provided core crisis communication tools to a major pipeline which is in the cross-hairs of several external stakeholders.
Device Panel + Advisory Committee
A biotech company sought approval of an aggressive treatment that combined a complex procedure with a strong chemotherapy agent. CCA readied the company’s team to present and defend their application for the drug plus isolation device.
Old Disease, New Strains
Influenza is a deadly disease and nature is constantly producing new strains. A pharmaceutical developed a new vaccine to counter a particularly deadly iteration of the flu. CCA prepared the sponsor’s team to present and defend an effective vaccine at Advisory Committee.
We continued to provide private coaching to corporate leaders. We offer tools and insights for leaders to develop, enhance, and in some cases change, their leadership style – internally and externally.
Large Transmission Project
Our client needed to build a transmission line across farmland, wildlife habitat, two state lines, and a major river. CCA helped the company’s witnesses refine positions on operational necessity, economic value, and benefits to customers.
Same Molecule, Faster Delivery
Children face a daunting daily regimen of drugs, supplements, and therapies for a particularly debilitating disease. Our client developed a new five-minute alternative to the standard hour-long treatment. CCA prepared the sponsor to address concerns from FDA’s Advisory Committee about this new delivery
New Generation of Witnesses
An electric utility had not filed a major rate case in 25 years. CCA developed a team of witnesses who had little or no experience defending a rate case before an aggressive state utility commission and a cast of tough intervenors.
Careful wording of a drug label is critical to pharmaceuticals as well as to the doctor and patient. Preparing for tough label negotiations, CCA helped the sponsor address FDA’s concerns and produce a clear and favorable label.
Two utilities formed an entity to tackle major transmission projects. State and federal regulators were sorting through issues of jurisdiction, while capacity needs and reliability were surging ahead of regulatory doctrine. CCA prepped witnesses to make a strong case for the new company and projects under a new paradigm.
Two companies proposed a complex transaction which would require approval at the federal level and five state jurisdictions. Before that, the parties had to iron out some major cultural and business differences. CCA’s witness development process brought the two sides together for some tough and necessary sessions.
When a regulatory entity ordered a corporation to transfer assets to another company, it created a complex integration of uncertainties across several jurisdictions. CCA worked with the witness and legal teams to identify and address issues, as well as prepare for all questions on the stand.
Air of Uncertainty
A utility’s IRP appropriately noted uncertainties related to pending air quality regulations, plant retirements, and sporadic renewable resources. CCA prepared company witnesses to present the plan and defend its inclusion of multiple uncertainties.
Compounding Mental Illness
Patients who present with schizophrenia and bipolar disorder have a dire need for effective treatment. CCA guided the sponsor to navigate through complex issues in preparation for Advisory Committee.
When a company had two transmission projects up for regulatory approval, it was essential that regulators and intervenors not exploit vulnerabilities of one project to the detriment of the other. Through the CCA process, company experts thoroughly explored both projects to find and eliminate this potential.
Regulators questioned investment in two new plants, as well as prudent management of existing plants to maintain reliability, avoid high-cost purchased power, and defer the need for new generation. The CCA team worked with witnesses to defend their actions and present clear evidence.
Tough Public Meetings
A utility had hundreds of millions of dollars in long-term contracts for renewables mandated by the state, when newly elected regulators abruptly changed direction. CCA prepared spokespersons to appear at multiple regulatory and public meetings to make a case for a steady course.
Raising Rates in Tough Economy
An energy company had lived with deficient rates for several years in a damaged state economy. It was time to remedy that, before reliability and new growth capacity suffered. CCA prepared witnesses to support a proposal for fair rates to accommodate recovery and emerging growth.
Major Depressive Disorder (MDD) poses a challenge for clinicians to match patients with safe, effective treatments. CCA readied a drug company to present solid data and analyses, as well as compelling arguments, for recommendation of FDA approval to market the drug.
Formula Rates No More
A non-US utility had been operating under formula-based rates for seven years, and it had not gone well. The company transitioned to cost-of-service rates and called on CCA to prepare witnesses to clearly explain the necessity of this change.
Note: Extensive issue research is conducted as a first step for all assignments.